Stockscreener 앱 받기
0.00
0.00%
0.00
전일 마감가:
$0.00
열려 있는:
$0
하루 거래량:
0
Relative Volume:
시가총액:
$N/A
수익:
$1.65M
순이익/손실:
$-5.91M
주가수익비율:
0.00
EPS:
-0.1707
순현금흐름:
$-3.03M
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.00
Vitro Biopharma, Inc. Stock (VTRO) Company Profile
명칭
Vitro Biopharma, Inc.
전화
(720) 859-4120
주소
4621 TECHNOLOGY DRIVE, GOLDEN
VTRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTRO
Vitro Biopharma, Inc.
|
0.00 | 0 | 1.65M | -5.91M | -3.03M | -0.1707 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Vitro Biopharma, Inc. 주식(VTRO)의 최신 뉴스
Vitro Biopharma Announces Early 2016 Results: Increased Revenue and Expansion Activities to Fuel Growth - ACCESS Newswire
Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World
Dealmaking Quarterly Statistics, Q2 2022 - insights.citeline.com
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - Yahoo Finance
Vitro Biopharma Products Advance Pancreatic Cancer Research - ACCESS Newswire
Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous Stem Cell Activation for Therapeutic Benefit - ACCESS Newswire
Best Biotech Stocks to Buy in 2025 - The Motley Fool
Vitro Biopharma Announces Advances in Stem Cell Therapy without Transplants - ACCESS Newswire
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
Reviewing Cyclo Therapeutics (NASDAQ:CYTH) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World
Financing Quarterly Statistics, Q4 2024 - Citeline
Vitro Biopharma, Inc. Reports Earnings Results for the Full Year Ended October 31, 2024 - Marketscreener.com
Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter - ACCESS Newswire
Vitro Diagnostics (OTCMKTS:VODG) & Inhibrx (NASDAQ:INBX) Head to Head Review - Defense World
Biopharmaceutical Culture Media Market Insight 2025 is Exhibitin - WICZ
In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
6 cultured meat companies making waves - Labiotech.eu
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire
Biopharmaceutical Culture Media Industry Trends & Drivers - Economica
Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights
FDA’s lab-developed test rule could be first test of agency’s power post-Chevron - BioPharma Dive
Vitro Biopharma, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - Yahoo Finance
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - PR Newswire
FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive
21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector - Built In
Swiss investment firm denies acquisition bid for Boryung Biopharma - KBR
Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc. - PR Newswire
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments - StockTitan
Siemens Healthineers considering $8 billion sale of in vitro diagnostics unit, announces 300 layoffs - DOTmed HealthCare Business News
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development - PR Newswire
In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research - Yahoo Finance
IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha
Startup aims to make lab-grown human eggs, transforming options for creating families - NPR
VTRO IPO NewsStem cell biotech Vitro Biopharma sets terms for $10 million IPO - renaissancecapital.com
CYPRE’S 3D in Vitro Platform Advances New Insights into the Tumor Microenvironment, Drives Data in 30 Days for Clients - Business Wire
Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire
This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF - STAT
Who are the leading innovators in in-vitro T-cell activation for the pharmaceutical industry? - Pharmaceutical Technology
Vitro Biopharma, Inc. announced a financing transaction -January 05, 2023 - Marketscreener.com
In Vitro Glycoengineering – Suitability For BioPharma Manufacturing - BioProcess Online
SeQure Dx Emerges From Stealth Mode to Fulfill the Promise of On-Target Gene Editing Therapies for Biopharma Partners, Physicians, and Patients - Business Wire
FUJIFILM Irvine Scientific PRIME-XV Stem FreezIS DMSO-Free Cryopreservation Medium to be Used in FDA-Authorized Clinical Trial - Business Wire
Vitro Biopharma Names Chris Furman Chief Executive Officer - Yahoo Finance
Understanding the promising opportunities for in-vitro diagnostics companies in the next decade - IQVIA
The 10 most innovative biotech companies in 2022 - Fast Company
Business of Biotechniques 2022 - BioTechniques
Can-Fite says Piclidenoson destroys pathological skin cells in vitro - Seeking Alpha
43 Top Biopharma Startups and Companies in Germany - EU-Startups
Vitro Biopharma, Inc. (VTRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.70%
자본화:
|
볼륨(24시간):